DRAP Introduces New Guidelines for Medicine Registration

For context, the Drug Regulatory Authority of Pakistan (DRAP) has notified new guidelines for the registration of medicines in the country in line with World Health Organization (WHO) guidelines.

Key points

• Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
• Add as a preferredSource on Google Follow on Google News Join WhatsApp.
• The new framework is projected to harmonize the regulatory review process for drug registration in Pakistan and improve accountability and transparency.
• The new framework is aimed at making the drug registration process more transparent, efficient, and consistent with international standards.
• While pharmaceutical firms will receive full facilitation during the submission of their applications, under the guidelines, applicants will be provided with complete information before registration.

Notably, the new framework is aimed at making the drug registration process more transparent, efficient, and consistent with international standards. Sindh Approves 13-Story Edhi Medical Tower at Children's Hospital.

DRAP has additionally taken international standards related to the quality and efficacy of medicines into account while developing the guidelines. Chery Q Cost in Pakistan Unveiled.

Notably, the new framework is projected to harmonize the regulatory review process for drug registration in Pakistan and improve accountability and transparency.

For context, a more efficient registration process is additionally anticipated to facilitate timely access to quality medicines in the country. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover.

In short, DRAP Introduces New Guidelines for Medicine Registration is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.